Chemistry · Glossary
HPLC
Also written: High-performance liquid chromatography · High-pressure liquid chromatography · RP-HPLC
Definition
HPLC separates a sample into its components to measure how much of it is the intended peptide — the source of the purity percentage on a COA.
HPLC purity peptide testing separates a dissolved sample into components and compares the detector signal from the intended peptide with signals from other resolved material. The resulting percentage answers “how much of the detected material belongs to the main peak under this method?” It does not, by itself, prove molecular identity, safety, sterility, or vial contents.
What is HPLC testing?
High-performance liquid chromatography (HPLC) is a laboratory technique that separates a mixture so its components can be detected and measured. For a peptide purity test, a small sample is dissolved, injected into a flowing liquid, and pushed through a packed column. Components leave the column at different times, producing separate peaks on a chromatogram.
The chromatogram is a graph: time runs across the bottom, while detector response rises vertically. Each resolved component appears as a peak. The area under a peak represents the amount of detector signal assigned to that component. The main peptide peak divided by the total integrated peak area produces the familiar purity percentage.
HPLC is a technique, not a verdict stamped onto a vial. An HPLC purity peptide result belongs to the sample, instrument, column, solvents, gradient, detector, and data-processing rules used for that run. Change the method and compounds that once overlapped may separate—or two previously distinct peaks may merge.
How HPLC works for peptides
Reversed-phase HPLC, usually shortened to RP-HPLC, separates peptides mainly by how strongly they interact with a water-repelling column surface. A liquid mixture of water and an organic solvent flows through the column. As the solvent composition changes, peptides and peptide-related impurities let go at different times. Think of runners leaving sticky starting blocks with different amounts of grip.
Peptide charge, hydrophobicity, size, column chemistry, temperature, and solvent conditions can all change retention. The NIH-hosted laboratory review of peptide HPLC describes reversed-phase HPLC as the most widely used mode for peptide separations and explains how gradients and column conditions alter resolution.
After separation, a detector records what exits. Ultraviolet detection is common because peptide bonds absorb UV light. Software integrates the peaks, meaning it calculates their areas. That is how HPLC works at the useful level: separate first, detect second, compare signals third.
What does HPLC purity 99% mean?
HPLC purity 99% usually means the assigned main peak contributed about 99% of the integrated detector signal included in that analysis. The remaining integrated peaks contributed about 1%. That is strong evidence of a chromatographically clean sample when the method can resolve relevant impurities and the target peak has been assigned correctly.
The wording matters. “99% of integrated signal” is not automatically “99% of every substance in the vial.” A detector only reports what the method separates, detects, and includes in its calculations. Two components can co-elute, leaving the column together as one peak. A component that responds differently to the detector can also distort a simple area comparison.
Preston and Phillips explain that peptide purity estimated from UV peak areas assumes UV absorbance is uniformly proportional to mass; because that assumption can fail, the estimate may be only semi-quantitative. HPLC purity 99% is useful. The decimal point does not make the method omniscient.
Does HPLC prove the peptide is the right molecule?
HPLC does not prove molecular identity by itself. HPLC shows that a component left a particular column at a particular time and generated a detector response. Calling that peak the intended peptide requires supporting evidence, such as comparison with a suitable reference and an orthogonal technique—one that measures a different property, commonly mass spectrometry.
FDA’s Q6A analytical guidance says identification based only on one chromatographic retention time is not sufficiently specific. The guidance accepts combinations such as HPLC with mass spectrometry because separation and molecular mass answer different questions.
That distinction is the clean boundary: HPLC answers “how much of the detected sample behaves as the assigned main component?” Identity testing asks “is that component the molecule named on the label?” A sample can produce one dominant peak without that peak being the intended peptide. Cleanly wrong is still wrong.
How much confidence should an HPLC number earn?
An HPLC number earns confidence from the evidence around it, not from the number of nines. A bare “99%” is a claim. A sample-specific chromatogram with a disclosed method is an inspectable measurement. A result from a suitable, validated method, paired with an independent identity test, is stronger evidence because more failure points have been checked.
This is an evidence ladder for the test, not a claim that HPLC needs human clinical trials. Analytical evidence answers a chemistry question. Clinical evidence answers whether a treatment helps people. Mixing those tiers produces impressive-looking paperwork that answers the wrong question.
Method suitability is the quiet hinge. The column and gradient must separate the target from plausible synthesis by-products or degradation products. Integration rules must count meaningful minor peaks rather than trimming the graph until it behaves. The detector must respond appropriately in the chosen range. No single purity threshold repairs a method that cannot see the relevant difference.
What would HPLC show for a peptide such as BPC-157?
For a BPC-157 sample, HPLC could separate the assigned BPC-157 peak from other detected components well enough to estimate relative chromatographic purity. HPLC alone could not establish that the main peak has BPC-157’s correct molecular mass, that the vial contains the labeled amount, or that the material is sterile or suitable for human use.
The same boundary applies across the peptide reference. HPLC is valuable because peptide synthesis can leave closely related material that separation may reveal. HPLC stays valuable when its claim stays narrow: purity under a stated method, for the sample actually tested.
For the paperwork around the result, use the full guide to reading a peptide COA. For sourcing and testing signals beyond the technique itself, see how to spot quality peptides. Those pages handle batch matching, identity reports, and broader quality checks; this glossary entry keeps HPLC in its proper lane.